Attenuated Listeria monocytogenes, a Mycobacterium tuberculosis ESAT-6 antigen expression and delivery vector for inducing an immune response

Research in Microbiology

Volumn 163, Issue 8, 2012, Pages 540-549

  Yin, Yuelan ^a   Tian, Debin ^a   Jia, Yanyan ^a   Gao, Yunfei ^a   Fu, Hong ^a   Niu, Zhongwei ^a   Sun, Lin ^a   Jiao, Xinan ^a  

^a YANGZHOU UNIVERSITY   (China)

Author keywords

Cellular immunity; ESAT 6 antigen; Listeria monocytogenes; Mycobacterium tuberculosis; Vector

Indexed keywords

BACTERIAL VECTOR; BCG VACCINE; ESAT 6 LISTERIOLYSIN O FUSION PROTEIN; GAMMA INTERFERON; HYBRID PROTEIN; INTERLEUKIN 4; LISTERIA MONOCYTOGENES VECTOR; LISTERIOLYSIN O; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOSOL; CYTOTOXIC T LYMPHOCYTE; DRUG DELIVERY SYSTEM; DRUG DOSE INCREASE; DRUG SAFETY; ESAT 6 GENE; FEMALE; HEMOLYSIS; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNOGENICITY; LISTERIA MONOCYTOGENES; MACROPHAGE; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; SPLEEN CELL; TH1 CELL; TUBERCULOSIS; VACCINATION;

ANIMALS; ANTIGENS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BACTERIAL TOXINS; CELL PROLIFERATION; CYTOTOXICITY TESTS, IMMUNOLOGIC; DISEASE MODELS, ANIMAL; DRUG CARRIERS; GENETIC VECTORS; HEAT-SHOCK PROTEINS; HEMOLYSIN PROTEINS; HEMOLYSIS; HISTOCYTOCHEMISTRY; LEUKOCYTES, MONONUCLEAR; LISTERIA MONOCYTOGENES; LISTERIOSIS; MACROPHAGES; MICE; MICE, INBRED C57BL; MYCOBACTERIUM TUBERCULOSIS; SPLEEN; SURVIVAL ANALYSIS; TH1 CELLS; TUBERCULOSIS VACCINES; VACCINES, ATTENUATED; VACCINES, SYNTHETIC; VIRULENCE;

LISTERIA MONOCYTOGENES; MUS; MYCOBACTERIUM TUBERCULOSIS;

EID: 84867629514     PISSN: 09232508     EISSN: 17697123     Source Type: Journal    
DOI: 10.1016/j.resmic.2012.07.008     Document Type: Article

References (36)

1. Angelakopoulos H., Loock K., Sisul D.M., Jensen E.R., Miller J.F., Hohmann E.L. Safety and shedding of an attenuated strain of L. monocytogenes with a deletion of actA/plcB in adult volunteers: a dose escalation study of oral inoculation. Infect. Immun. 2002, 70:3592-3601.
2. Baumann S., Nasser Eddine A., Kaufmann S.H. Progress in tuberculosis vaccine development. Curr. Opin. Immunol. 2006, 18:438-448.
3. Brodin P., Rosenkrands I., Andersen P., Cole S.T., Brosch R. ESAT-6 proteins: protective antigens and virulence factors?. Trends Microbiol. 2004, 12:500-508.
4. Brundage R.A., Smith G.A., Camilli A., Theriot J.A., Portnoy D.A. Expression and phosphorylation of the Listeria monocytogenes ActA protein in mammalian cells. Proc. Natl. Acad. Sci. U S A 1993, 90:11890-11894.
5. Buddle B.M., Wedlock D.N., Denis M. Progress in the development of tuberculosis vaccines for cattle and wildlife. Vet. Microbiol. 2006, 112:191-200.
6. Camejo A., Buchrieser C., Couvé E., Carvalho F., Reis O., Ferreira P., Sousa S., Cossart P., Cabanes D. In vivo transcriptional profiling of Listeria monocytogenes and mutagenesis identify new virulence factors involved in infection. PLoS Pathog. 2009, 5:e1000449.
7. Camejo A., Carvalho F., Reis O., Leitão E., Sousa S., Cabanes D. The arsenal of virulence factors deployed by Listeria monocytogenes to promote its cell infection cycle. Virulence 2011, 2:379-394.
8. Coles R.M., Mueller S.N., Heath W.R., Carbone F.R., Brooks A.G. Progression of armed CTL from draining lymph node to spleen shortly after localized infection with herpes simplex virus 1. J. Immunol. 2002, 168:834-838.
9. Decatur A.L., Portnoy D.A. A PEST-like sequence in listeriolysin O essential for Listeria monocytogenes pathogenicity. Science 2000, 290:992-995.
10. Dietrich J., Weldingh K., Andersen P. Prospects for a novel vaccine against tuberculosis. Vet. Microbiol. 2006, 112:163-169.
11. Good M., Duignan A. Perspectives on the history of bovine TB and the role of tuberculin in bovine TB eradication. Vet. Med. Int. 2011, 410470.
12. Hlavsa M.C., Moonan P.K., Cowan L.S., Navin T.R., Kammerer J.S., Morlock G.P., Crawford J.T., Lobue P.A. Human tuberculosis due to Mycobacterium bovis in the United States. Clin. Infect. Dis. 2008, 47:168-175.
13. Jia Q., Lee B.Y., Clemens D.L., Bowen R.A., Horwitz M.A. Recombinant attenuated Listeria monocytogenes vaccine expressing Francisella tularensis IglC induces protection in mice against aerosolized Type A F. tularensis. Vaccine 2009, 27:1216-1229.
14. Jiang L.L., Song H.H., Chen X.Y., Ke C.L., Xu J.J., Chen N., Fang W.H. Characterization of a mutant Listeria monocytogenes strain expressing green fluorescent protein. Acta Biochim. Biophys. Sin. 2005, 37:19-24.
15. Jiao X., Lo-Man R., Guermonprez P., Fiette L., Deriaud E., Burgaud S., Gicquel B., Winter N., Leclerc C. Dendritic cells are host cells for mycobacteria in vivo that trigger innate and acquired immunity. J. Immunol. 2002, 168:1294-1301.
16. Kaufmann S.H. Future vaccination strategies against tuberculosis: thinking outside the box. Immunity 2010, 33:567-577.
17. Kawamura I., Tsukada H., Yoshikawa H., Fujita M., Nomoto K., Mitsuyama M. IFN-gamma-producing ability as a possible marker for the protective T cells against Mycobacterium bovis BCG in mice. J. Immunol. 1992, 148:2887-2893.
18. Langermans J.A., Doherty T.M., Vervenne R.A., van der Laan T., Lyashchenko K., Greenwald R., Agger E.M., Aagaard C., Weiler H., van Soolingen D., Dalemans W., Thomas A.W., Andersen P. Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6. Vaccine 2005, 23:2740-2750.
19. Mahairas G.G., Sabo P.J., Hickey M.J., Singh D.C., Stover C.K. Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J. Bacteriol. 1996, 178:1274-1282.
20. Martin C. The dream of a vaccine against tuberculosis; new vaccines improving or replacing BCG?. Eur. Respir. J. 2005, 26:162-167.
21. McNair J., Welsh M.D., Pollock J.M. The immunology of bovine tuberculosis and progression toward improved disease control strategies. Vaccine 2007, 25:5504-5511.
22. Michel A.L., Müller B., van Helden P.D. Mycobacterium bovis at the animal-human interface: a problem, or not?. Vet. Microbiol. 2010, 140:371-381.
23. Miki K., Nagata T., Tanaka T., Kim Y.H., Uchijima M., Ohara N., Nakamura S., Okada M., Koide Y. Induction of protective cellular immunity against Mycobacterium tuberculosis by recombinant attenuated self-destructing Listeria monocytogenes strains harboring eukaryotic expression plasmids for antigen 85 complex and MPB/MPT51. Infect. Immun. 2004, 72:2014-2021.
24. Park S.F., Stewart G.S. High-efficiency transformation of Listeria monocytogenes by electroporation of penicillin-treated cells. Gene 1990, 94:129-132.
25. Schoen C., Loeffler D.I., Frentzen A., Pilgrim S., Goebel W., Stritzker J. Listeria monocytogenes as novel carrier system for the development of live vaccines. Int. J. Med. Microbiol. 2008, 298:45-58.
26. Sciaranghella G., Lakhashe S.K., Ayash-Rashkovsky M., Mirshahidi S., Siddappa N.B., Novembre F.J., Velu V., Amara R.R., Zhou C., Li S., Li Z., Frankel F.R., Ruprecht R.M. A live attenuated Listeria monocytogenes vaccine vector expressing SIV Gag is safe and immunogenic in macaques and can be administered repeatedly. Vaccine 2011, 29:476-486.
27. Sharma A.K., Khuller G.K. DNA vaccines: future strategies and relevance to intracellular pathogens. Immunol. Cell. Biol. 2001, 79:537-546.
28. Singh R., Dominiecki M.E., Jaffee E.M., Paterson Y. Fusion to listeriolysin O and delivery by Listeria monocytogenes enhances the immunogenicity of HER-2/neu and reveals subdominant epitopes in the FVB/N mouse. J. Immunol. 2005, 175:3663-3673.
29. Stavru F., Archambaud C., Cossart P. Cell biology and immunology of Listeria monocytogenes infections: novel insights. Immunol. Rev. 2010, 240:160-184.
30. Van Langendonck N., Bottreau E., Bailly S., Tabouret M., Marly J., Pardon P., Velge P. Tissue culture assays using Caco-2 cell line differentiate virulent from non-virulent Listeria monocytogenes strains. J. App. Microbiol. 1998, 85:337-346.
31. Warrens A.N., Jones M.D., Lechler R.I. Splicing by overlap extension by PCR using asymmetric amplification: an improved technique for the generation of hybrid proteins of immunological interest. Gene 1997, 186:29-35.
32. Wirth T., Hildebrand F., Allix-Béguec C., Wölbeling F., Kubica T., Kremer K., van Soolingen D., Rüsch-Gerdes S., Locht C., Brisse S., Meyer A., Niemann S., Supply P. Origin, spread and demography of the Mycobacterium tuberculosis complex. PLoS Pathog. 2008, 4:e1000160.
33. Xu Y., Zhu B., Wang Q., Chen J., Qie Y., Wang J., Wang H., Wang B., Wang H. Recombinant BCG coexpressing Ag85B, ESAT-6 and mouse-IFN-gamma confers effective protection against Mycobacterium tuberculosis in C57BL/6 mice. FEMS Immunology and Medical Microbiology 2007, 51:480-487.
34. Yin Y., Zhu G., Geng S., Hu M., Jiao X. Construction and characterization of a mutant strain of Listeria monocytogenes with a deletion of actA and plcB. Wei Sheng Wu Xue Bao 2008, 48:299-303.
35. Yin Y., Tian D., Zhang C., Pan Z., Zhang X., Wang X., Jiao X. Pathogenicity and immunogenicity of a mutant strain of Listeria monocytogenes in the chicken infection model. Clin. Vaccine Immunol. 2011, 18:500-505.
36. Yoshimura K., Jain A., Allen H.E., Laird L.S., Chia C.Y., Ravi S., Brockstedt D.G., Giedlin M.A., Bahjat K.S., Leong M.L., Slansky J.E., Cook D.N., Dubensky T.W., Pardoll D.M., Schulick R.D. Selective targeting of antitumor immune responses with engineered live-attenuated Listeria monocytogenes. Cancer Res. 2006, 66:1096-1104.